Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

Pathways involved in the synergistic activation of macrophages by lipoteichoic acid and hemoglobin.

Cox KH, Cox ME, Woo-Rasberry V, Hasty DL.

PLoS One. 2012;7(10):e47333. doi: 10.1371/journal.pone.0047333. Epub 2012 Oct 10.

2.

The NH(2)-terminal region of Streptococcus pyogenes M5 protein confers protection against degradation by proteases and enhances mucosal colonization of mice.

Penfound TA, Ofek I, Courtney HS, Hasty DL, Dale JB.

J Infect Dis. 2010 May 15;201(10):1580-8. doi: 10.1086/652005.

3.

Inactivation of DltA modulates virulence factor expression in Streptococcus pyogenes.

Cox KH, Ruiz-Bustos E, Courtney HS, Dale JB, Pence MA, Nizet V, Aziz RK, Gerling I, Price SM, Hasty DL.

PLoS One. 2009;4(4):e5366. doi: 10.1371/journal.pone.0005366. Epub 2009 Apr 29.

4.

Relationship between expression of the family of M proteins and lipoteichoic acid to hydrophobicity and biofilm formation in Streptococcus pyogenes.

Courtney HS, Ofek I, Penfound T, Nizet V, Pence MA, Kreikemeyer B, Podbielski A, Hasty DL, Dale JB.

PLoS One. 2009;4(1):e4166. doi: 10.1371/journal.pone.0004166. Epub 2009 Jan 9. Erratum in: PLoS ONE. 2009;28(2). doi: 10.1371/annotation/823215e6-c06a-4d5f-ac7b-0ee77067ccb2. PLoS ONE. 2009;4(1). doi: 10.1371/annotation/c2f3e4e5-b6a0-4be8-9f8c-3d4e01933385. Podbielbski, Andreas [corrected to Podbielski, Andreas].

5.

Lipoteichoic acid synergizes with glycosphingolipids to potently stimulate secretion of interleukin-6 from human blood cells.

Meron-Sudai S, Matityahou A, Keisari Y, Cox KH, Hasty DL, Ofek I.

Clin Vaccine Immunol. 2008 Sep;15(9):1309-15. doi: 10.1128/CVI.00060-08. Epub 2008 Jul 16.

6.
7.

Monocyte and macrophage activation by lipoteichoic Acid is independent of alanine and is potentiated by hemoglobin.

Hasty DL, Meron-Sudai S, Cox KH, Nagorna T, Ruiz-Bustos E, Losi E, Courtney HS, Mahrous EA, Lee R, Ofek I.

J Immunol. 2006 May 1;176(9):5567-76.

8.

Anti-phagocytic mechanisms of Streptococcus pyogenes: binding of fibrinogen to M-related protein.

Courtney HS, Hasty DL, Dale JB.

Mol Microbiol. 2006 Feb;59(3):936-47.

9.

Defective expression of Tamm-Horsfall protein/uromodulin in COX-2-deficient mice increases their susceptibility to urinary tract infections.

Dou W, Thompson-Jaeger S, Laulederkind SJ, Becker JW, Montgomery J, Ruiz-Bustos E, Hasty DL, Ballou LR, Eastman PS, Srichai B, Breyer MD, Raghow R.

Am J Physiol Renal Physiol. 2005 Jul;289(1):F49-60. Epub 2005 Mar 1.

10.

Tamm-Horsfall protein is a critical renal defense factor protecting against calcium oxalate crystal formation.

Mo L, Huang HY, Zhu XH, Shapiro E, Hasty DL, Wu XR.

Kidney Int. 2004 Sep;66(3):1159-66.

11.

Commonly used antibiotics induce expression of Hsp 27 and Hsp 60 and protect human lymphocytes from apoptosis.

Romano CC, Benedetto N, Catania MR, Rizzo A, Gallè F, Losi E, Hasty DL, Rossano F.

Int Immunopharmacol. 2004 Aug;4(8):1067-73.

PMID:
15222981
12.

Ablation of the Tamm-Horsfall protein gene increases susceptibility of mice to bladder colonization by type 1-fimbriated Escherichia coli.

Mo L, Zhu XH, Huang HY, Shapiro E, Hasty DL, Wu XR.

Am J Physiol Renal Physiol. 2004 Apr;286(4):F795-802. Epub 2003 Dec 9.

13.

Anti-adhesion therapy of bacterial diseases: prospects and problems.

Ofek I, Hasty DL, Sharon N.

FEMS Immunol Med Microbiol. 2003 Oct 15;38(3):181-91. Review.

15.

Chlamydia pneumoniae infections prevent the programmed cell death on THP-1 cell line.

Carratelli CR, Rizzo A, Catania MR, Gallè F, Losi E, Hasty DL, Rossano F.

FEMS Microbiol Lett. 2002 Sep 24;215(1):69-74.

16.

Molecular mechanisms of adhesion, colonization, and invasion of group A streptococci.

Courtney HS, Hasty DL, Dale JB.

Ann Med. 2002;34(2):77-87. Review.

PMID:
12108578
17.

Cytokine induction in murine bladder tissue by type 1 fimbriated Escherichia coli.

Carbone M, Hasty DL, Yi KC, Rue J, Fera MT, La Torre F, Giannone M, Losi E.

Ann N Y Acad Sci. 2002 Jun;963:332-5.

PMID:
12095961
18.

p53 and anti-p53 antibodies as possible markers of a switch towards a neoplastic phenotype in patients infected by Helicobacter pylori.

Losi E, Molinari AM, Gazzerro P, Ortega De Luna L, Fera MT, Carbone M, Catania MR, Hasty DL, Rossano F.

Ann N Y Acad Sci. 2002 Jun;963:329-31.

PMID:
12095960
19.

Mapping the fibrinogen-binding domain of serum opacity factor of group a streptococci.

Courtney HS, Dale JB, Hasty DL.

Curr Microbiol. 2002 Apr;44(4):236-40.

PMID:
11910491
20.
21.
22.

Valency conversion in the type 1 fimbrial adhesin of Escherichia coli.

Sokurenko EV, Schembri MA, Trintchina E, Kjaergaard K, Hasty DL, Klemm P.

Mol Microbiol. 2001 Aug;41(3):675-86.

23.

Spa contributes to the virulence of type 18 group A streptococci.

McLellan DG, Chiang EY, Courtney HS, Hasty DL, Wei SC, Hu MC, Walls MA, Bloom JJ, Dale JB.

Infect Immun. 2001 May;69(5):2943-9.

24.

Tamm-Horsfall protein binds to type 1 fimbriated Escherichia coli and prevents E. coli from binding to uroplakin Ia and Ib receptors.

Pak J, Pu Y, Zhang ZT, Hasty DL, Wu XR.

J Biol Chem. 2001 Mar 30;276(13):9924-30. Epub 2000 Dec 27.

25.

Role of bacterial lectins in urinary tract infections. Molecular mechanisms for diversification of bacterial surface lectins.

Ofek I, Hasty DL, Abraham SN, Sharon N.

Adv Exp Med Biol. 2000;485:183-92. Review. No abstract available.

PMID:
11109105
26.

Pathoadaptive mutations: gene loss and variation in bacterial pathogens.

Sokurenko EV, Hasty DL, Dykhuizen DE.

Trends Microbiol. 1999 May;7(5):191-5.

PMID:
10354593
27.

New protective antigen of group A streptococci.

Dale JB, Chiang EY, Liu S, Courtney HS, Hasty DL.

J Clin Invest. 1999 May;103(9):1261-8.

28.

Serum opacity factor is a major fibronectin-binding protein and a virulence determinant of M type 2 Streptococcus pyogenes.

Courtney HS, Hasty DL, Li Y, Chiang HC, Thacker JL, Dale JB.

Mol Microbiol. 1999 Apr;32(1):89-98.

29.

Pathogenic adaptation of Escherichia coli by natural variation of the FimH adhesin.

Sokurenko EV, Chesnokova V, Dykhuizen DE, Ofek I, Wu XR, Krogfelt KA, Struve C, Schembri MA, Hasty DL.

Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8922-6.

30.

Diversity of the Escherichia coli type 1 fimbrial lectin. Differential binding to mannosides and uroepithelial cells.

Sokurenko EV, Chesnokova V, Doyle RJ, Hasty DL.

J Biol Chem. 1997 Jul 11;272(28):17880-6.

31.
33.

M protein expression is not required for resistance to phagocytosis of type 18 group A streptococci.

Liu S, Courtney HS, Bessen DE, Hasty DL, Dale JB.

Adv Exp Med Biol. 1997;418:725-7. No abstract available.

PMID:
9331754
34.

Host cell specific adhesins of group A streptococci.

Courtney HS, Dale JB, Hasty DL.

Adv Exp Med Biol. 1997;418:605-6. No abstract available.

PMID:
9331724
35.

Linker insertion analysis of the FimH adhesin of type 1 fimbriae in an Escherichia coli fimH-null background.

Schembri MA, Pallesen L, Connell H, Hasty DL, Klemm P.

FEMS Microbiol Lett. 1996 Apr 1;137(2-3):257-63.

PMID:
8998995
36.

The FimH protein of type 1 fimbriae. An adaptable adhesin.

Klemm P, Schembri M, Hasty DL.

Adv Exp Med Biol. 1996;408:193-5. Review. No abstract available.

PMID:
8895793
37.

Group A streptococcal adhesion. All of the theories are correct.

Hasty DL, Courtney HS.

Adv Exp Med Biol. 1996;408:81-94. Review. No abstract available.

PMID:
8895780
38.

Quantitative differences in adhesiveness of type 1 fimbriated Escherichia coli due to structural differences in fimH genes.

Sokurenko EV, Courtney HS, Maslow J, Siitonen A, Hasty DL.

J Bacteriol. 1995 Jul;177(13):3680-6.

39.
40.

Bacterial adhesion measured by growth of adherent organisms.

Sokurenko EV, McMackin VA, Hasty DL.

Methods Enzymol. 1995;253:519-28. No abstract available.

PMID:
7476414
41.

Assay for adhesion of host cells to immobilized bacteria.

Sokurenko EV, Hasty DL.

Methods Enzymol. 1995;253:220-6. No abstract available.

PMID:
7476388
42.
43.
44.

Passive protection of mice against group A streptococcal pharyngeal infection by lipoteichoic acid.

Dale JB, Baird RW, Courtney HS, Hasty DL, Bronze MS.

J Infect Dis. 1994 Feb;169(2):319-23.

PMID:
8106764
45.

FimH family of type 1 fimbrial adhesins: functional heterogeneity due to minor sequence variations among fimH genes.

Sokurenko EV, Courtney HS, Ohman DE, Klemm P, Hasty DL.

J Bacteriol. 1994 Feb;176(3):748-55.

46.

Genetic exchange of determinants for capsular polysaccharide biosynthesis between Klebsiella pneumoniae strains expressing serotypes K2 and K21a.

Ofek I, Kabha K, Athamna A, Frankel G, Wozniak DJ, Hasty DL, Ohman DE.

Infect Immun. 1993 Oct;61(10):4208-16.

47.

A 28-kilodalton fibronectin-binding protein of group A streptococci.

Courtney HS, Hasty DL, Dale JB, Poirier TP.

Curr Microbiol. 1992 Nov;25(5):245-50.

PMID:
1369195
48.

Functional heterogeneity of type 1 fimbriae of Escherichia coli.

Sokurenko EV, Courtney HS, Abraham SN, Klemm P, Hasty DL.

Infect Immun. 1992 Nov;60(11):4709-19.

49.

Glycerol-induced unraveling of the tight helical conformation of Escherichia coli type 1 fimbriae.

Abraham SN, Land M, Ponniah S, Endres R, Hasty DL, Babu JP.

J Bacteriol. 1992 Aug;174(15):5145-8.

50.

Multiple adhesins of streptococci.

Hasty DL, Ofek I, Courtney HS, Doyle RJ.

Infect Immun. 1992 Jun;60(6):2147-52. Review. No abstract available.

Supplemental Content

Loading ...
Support Center